Pub. Date : 2020 Mar
PMID : 32186787
2 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
| 1 | Recently, phase 3 studies have shown that ovarian cancer patients with recurrent, platinum sensitive disease who were treated with PARP inhibitors have shown statistically significant improvement in progression free survival. | Platinum | poly(ADP-ribose) polymerase 1 | Homo sapiens |
| 2 | Following these studies, the FDA and the European authorities granted an accelerated approval for the use of PARP inhibitors as maintenance treatment after first line treatment, for BRCA carriers, and at the recurrence for platinum sensitive patients. | Platinum | poly(ADP-ribose) polymerase 1 | Homo sapiens |